VS
BMO SPDR Health Care Select Sector Index ETF (ZXLV) and Harvest Healthcare Leaders Income ETF (HHL) offer distinct profiles for Canadian ETF investors. A direct comparison shows that ZXLV focuses its top 3 sector exposures on Healthcare and Consumer Non-Cyclicals, while HHL leans towards Healthcare and Sovereign. When evaluating costs, ZXLV features a management fee (MER) of 0.21%, compared to 0.85% for HHL. Performance-wise, ZXLV has returned 8.67% year-to-date with +$24 M in net flows, whereas HHL is at 0.84% with +$358 M. Use the comparison tool below to benchmark these funds across top 10 holdings, yield, sector weights and historical returns.
NAV Performance and Flows
Key Data
Compare
ZXLV
HHL
| AuM | $39.83 M | $1,827.10 M |
| Management Fees | 0.21% | 0.85% |
| Exp. ratio | 0.21% | 0.98% |
| Tracking Difference | - | - |
Historical performance and flows
As of September 11, 2026
| 1M | 3M | YTD | 1Y | 3Y | ||
|---|---|---|---|---|---|---|
| Perf. | ZXLV | -2.01% | +6.99% | +8.67% | +20.31% | - |
HHL | -3.81% | +5.43% | -0.84% | +7.83% | +18.09% | |
| Flows | ZXLV | -$5 M | +$17 M | +$24 M | +$34 M | - |
HHL | +$4 M | +$45 M | +$358 M | +$359 M | +$691 M |
ZXLV vs HHL exposure
Countries
ZXLV
USA
97.53%
HHL
USA
84.21%
Other
15.79%
Sectors
ZXLV
Healthcare
97.51%
HHL
Healthcare
98.89%
As of September 11, 2026
Top 10 Holdings
ZXLV
Eli Lilly & Co.
15.48%
Johnson & Johnson
10.51%
AbbVie, Inc.
7.55%
UnitedHealth Group, Inc.
6.41%
Merck & Co., Inc.
5.48%
Thermo Fisher Scientific, Inc.
3.64%
Amgen, Inc.
3.54%
Abbott Laboratories
3.14%
Gilead Sciences, Inc.
2.75%
Pfizer Inc.
2.43%
HHL
Regeneron Pharmaceuticals, Inc.
5.34%
Boston Scientific Corp.
5.14%
Bristol Myers Squibb Co.
5.10%
Thermo Fisher Scientific, Inc.
5.00%
Merck & Co., Inc.
4.99%
Elevance Health, Inc.
4.99%
Amgen, Inc.
4.95%
Agilent Technologies, Inc.
4.95%
Intuitive Surgical, Inc.
4.94%
UnitedHealth Group, Inc.
4.94%
Diversification
ZXLV
Total weight of top 10 holdings out of 59 total
60.94%
HHL
Total weight of top 10 holdings out of 25 total
50.34%
Characteristics
Compare
ZXLV
HHL
| Provider | BMO | Harvest Portfolios Group |
| Management | Passively managed | Actively managed |
| Benchmark | S&P Health Care Select Sector Total Return Index - USD | - |
| Replication Method | ||
| Asset Class | Equity | Equity |
| Dividend Policy | Distributing | Distributing |
| Trailing 12m distribution yield | 0.46% | 10.08% |
| Meets ESG criteria | No | No |
| Inception Date | February 2, 2025 | December 18, 2014 |
Frequently asked questions about ZXLV and HHL
Which ETF has performed better year to date: ZXLV or HHL?
As of September 11, 2026, ZXLV has returned 8.67% year to date, while HHL has returned -0.84%. ZXLV is ahead on YTD performance.
Which ETF is larger by assets under management: ZXLV or HHL?
As of September 11, 2026, ZXLV manages $39.83 M in assets, while HHL manages $1.83 B. HHL is the larger fund by AUM.
How are ZXLV and HHL managed?
ZXLV is passively managed by BMO. It tracks the S&P Health Care Select Sector Total Return Index - USD benchmark. HHL is actively managed by Harvest Portfolios Group. It does not track an index.
What sectors do ZXLV and HHL emphasize?
ZXLV is most exposed to Healthcare and Consumer Non-Cyclicals. HHL is most exposed to Healthcare and Sovereign.
Which ETF is attracting more investor flows: ZXLV or HHL?
Year to date, ZXLV has seen +$23.63 M in net flows, compared with +$357.74 M for HHL. HHL has attracted more net investor money so far.
How do the fees of ZXLV and HHL compare?
ZXLV has an expense ratio of 0.21%, while HHL has an expense ratio of 0.98%.
What are the top holdings of ZXLV and HHL?
ZXLV's largest holdings include Eli Lilly & Co., Johnson & Johnson, and AbbVie, Inc.. HHL's top holdings include Regeneron Pharmaceuticals, Inc., Boston Scientific Corp., and Bristol Myers Squibb Co..
Which ETF is more diversified: ZXLV or HHL?
ZXLV holds 59 securities, while HHL holds 25. On holdings count, ZXLV is the more diversified portfolio.
Recent articles about ZXLV and HHL
The ETF Market Canada is brought to you by Cboe in partnership with Trackinsight SA who is providing all the data, analysis and editorial content on this site. Unless explicitly stated as such, any information that you receive is not real-time.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.